DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Search Companies Events Environment Memories Home-Biotech

AbAg | Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Alphelys | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Atlantic Bone Screen | Aureus Pharma | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Cellectis | Cellial Technologies | CellVax | CellVir | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytomics | DBV Technologies | Diatos | DNA Therapeutics | Domain Therapeutics | Dynabio | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | Fovea Pharmaceuticals | GemacBio | Genepep | Genewave | Genfit | GenOdyssee | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | GTP Technology | Helios Biosciences | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | Innate Pharma | InnaVirVax | IntegraGen | Ipsogen | I-Stem | Ivagen | Karcinolys | Keosys | LibraGen | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Meristem Therapeutics | MicroBioChips | MilleGen | MitoProd | Murigenetics | Mutabilis | Myosix | NanoBiotix | Nautilus Biotech | Neorphys | Neovacs | Netris-Pharma | Neuronax | NicOx | Nokad | Nova Decision | Novagali | Novexel | NovoCIB | Novotec | ObeTherapy | Oligovax | Oncodesign | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | PraXcell | Proteogenix | Protéus | Protexel | PX’Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | ShigaMediX | Sisène Biotechnologies | Skuld-Tech | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theraptosis | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Urrma | Vaxon Biotech | Vectalys | VigiCell | Vivalis | XenTech |

* BIOSYSTEMS INTERNATIONAL *

2004 - IDF
Évry
(near Paris)
www.biosys-intl.com

Design, Diagnostics
Key words: Biomarkers, Drug discovery improvement, Development productivity, Serum proteins
Mission: to discover and validate biomarkers through partnerships with pharmaceutical, biotechnology and diagnostics companies and in-house research programs or academic collaborations
Clients: Pharmaceutical industry (AstraZeneca), Biotechs
info@biosys-intl.com

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Spin-off |
Managing Dir.: Tirouflet (Jean-Pierre) [born 1950, ENA, ex-Rhodia (President), MEDEF, Rhône-Poulenc, Finance Ministry, Crédit National Bank
Sc.Dir.: Takacs (Laszlo) [co-founder, born 1955, M.D., Ph.D., ex-Pfizer, Parke Davis, Amgen, NIH]
Tech.Dir.: Guttman (András) [co-founder, Ph.D. Chemistry, ex-Beckman Coulter]
Fin.Dir.: Liebaert (François) [MBA, ex-Schering, Abbott]
BusDev: Liebaert (François)
Financers: Société Générale
Note : a susidiary (research) in Hungary

Turnover (M€) : 0.11 (2006)
Total funding (M€) : 6.5
Last funding (M€) : 3.5
Focus : Multiple
Position : Trade
Company confirm : none

History
DATEMILESTONETYPETIME
2008 .10 2nd round-financing : 3.5 M€ led by SGAM AI, with undisclosed private investors in order to foster R&D of lung, colon and breast cancer diagnostics to be marketed in 2010 RFINB [4 years]
2007 .03 Nomination : Jean-Pierre Tirouflet as CEO, replacing co-founder ORGN [3 years]
2006 .03 Partnering research agreement with AstraZeneca on arthrosis biomarkers R&D [2 years]
2005 .01 1st round-financing : 3.0 M€, by Société Générale A.M. RFINA [1 year]
2004 .05 Company founded by Laszlo Takacs, Andras Guttman, Barry L. Karger, William S. Hancock, as a spin-off from Pfizer France R&D center of Fresnes (Parke Davis Jouveinal), with name shortened as BSI ORGF [0 year]

Actualisation / Updating: 31-Oct-2008

Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT
Pour retourner à la page d'accueil Biotech: BIENVENUE !

Haut de page :

Copyright J.H. Huber, Pharmaclient 2001-2008.

Pharmaclient, le site de la valorisation client en Pharma, est la vitrine des activités de conseil de Jean Huber: Stratégie, Communication, Relation Client en Pharma.